Word Finding Difficulty: Labs, Diagnosis, and Next Steps

What Word Finding Difficulty Actually Means

Anomia is the clinical term for difficulty retrieving a known word during speech. The word exists in your vocabulary. You recognize it when someone else says it. But the retrieval pathway stalls, producing pauses, circumlocutions ("the thing you use to..."), or substitutions of a related but incorrect word.

This is different from never having learned a word or losing comprehension of its meaning. The distinction matters because retrieval failures and semantic losses point to different neuroanatomical circuits. Retrieval-type anomia localizes most often to the left temporal lobe, particularly the posterior superior and middle temporal gyri, while semantic-type anomia implicates the anterior temporal lobes bilaterally [2].

Everyone experiences occasional tip-of-tongue (TOT) states. A 2011 diary study published in the Journal of Experimental Psychology found that young adults average about one TOT episode per week, while adults over 65 average two to four per week [3]. The frequency increases with age even in the absence of pathology. What separates normal aging from a clinical concern is the trajectory: stable frequency over months is reassuring, while a noticeable increase over weeks to months warrants investigation.

Anomia can appear as the earliest and sometimes the only symptom of conditions ranging from a sluggish thyroid to primary progressive aphasia. The clinical question is never "is this normal?" in isolation. The question is whether it represents a change from your baseline, and if so, what is driving it.

Why You Might Be Experiencing Word Finding Difficulty

The causes divide into five broad categories, and several can overlap in a single patient. Metabolic and endocrine disorders top the list of reversible etiologies. Hypothyroidism slows processing speed and word retrieval; a 2015 meta-analysis of 13 studies (N = ,770) in Thyroid found consistent impairments in verbal memory and fluency among patients with subclinical and overt hypothyroidism [4]. B12 deficiency impairs myelin integrity in the central nervous system and can produce word finding difficulty, confusion, and personality changes well before macrocytic anemia appears on a CBC [5].

Hyponatremia (serum sodium <130 mEq/L) is an underrecognized cause. Even "mild" chronic hyponatremia (sodium 130 to 135 mEq/L) was associated with a 2.5-fold increased risk of attention and verbal fluency deficits in a cross-sectional analysis of 5,435 participants from the Rotterdam Study [6].

Neurodegenerative causes include Alzheimer disease, frontotemporal dementia (particularly the logopenic and semantic variants of primary progressive aphasia), and Lewy body dementia. Among these, the logopenic variant of PPA presents with isolated word finding difficulty for months to years before other cognitive domains decline [7].

Psychiatric conditions cause word finding trouble more often than patients or clinicians expect. Major depressive disorder reduces verbal fluency, with a meta-analysis of 38 studies (N = 2,949) showing a moderate effect size (Cohen's d = 0.59) on phonemic fluency tasks [8]. Sleep deprivation is another offender: restricting healthy adults to four hours of sleep for six nights produced verbal fluency deficits equivalent to a blood alcohol concentration of 0.10% in a University of Pennsylvania study [9].

Medication side effects deserve their own workup. See the dedicated section below.

The Lab Panel Your Doctor Should Order

A 2020 American Academy of Neurology (AAN) practice guideline update for the evaluation of suspected cognitive decline recommends a core blood panel before any imaging [1]. The goal is to identify or exclude reversible contributors.

Core panel:

• TSH and free T4. Hypothyroidism is present in about 5% of adults over 60 and may present solely with cognitive complaints [4].
• Vitamin B12. Serum B12 below 300 pg/mL with elevated methylmalonic acid (MMA) confirms functional deficiency. The Framingham Offspring Study found that 12% of community-dwelling elderly had B12 levels in the deficient or marginal range [5].
• CBC with differential. Screens for anemia, infection, and hematologic malignancy.
• Comprehensive metabolic panel (CMP). Captures sodium, calcium, glucose, renal function, and hepatic function. Hypercalcemia, uremia, and hepatic encephalopathy all impair word retrieval.
• Folate. Low folate independently contributes to hyperhomocysteinemia and cognitive impairment.
• RPR or VDRL. Neurosyphilis remains in the differential for any unexplained cognitive change, particularly in high-prevalence populations [10].

Extended panel (ordered based on clinical suspicion):

• HIV antibody/antigen. HIV-associated neurocognitive disorder (HAND) affects up to 50% of people living with HIV and commonly presents with verbal fluency deficits [11].
• ESR and CRP. When vasculitis or autoimmune encephalitis is considered.
• Heavy metals (lead, mercury, arsenic). Occupational or environmental exposure history guides this decision.
• Hemoglobin A1c. Type 2 diabetes accelerates cognitive decline; the ACCORD-MIND trial (N = 2,977) showed that participants with A1c above 8% had greater declines in processing speed over 40 months [12].
• Cortisol (morning or 24-hour urine free cortisol). Cushing syndrome and chronic exogenous glucocorticoid use impair hippocampal function and verbal memory [13].

A normal core panel does not end the workup. It narrows it. If labs are unremarkable and word finding difficulty is progressive, the next step is imaging.

Imaging and Neuropsychological Testing

MRI of the brain with thin-cut coronal sequences through the hippocampi is the recommended first-line imaging study per AAN guidelines [1]. The scan evaluates for structural lesions (tumor, stroke, subdural hematoma, normal pressure hydrocephalus), white matter disease burden, and patterns of cortical atrophy. Left temporal atrophy disproportionate to the right raises suspicion for logopenic variant PPA or Alzheimer-type pathology.

If MRI is contraindicated, CT head with contrast provides a limited but acceptable alternative. CT will identify mass lesions and hydrocephalus but lacks the resolution to assess hippocampal volumes or subtle cortical atrophy patterns.

FDG-PET becomes relevant when the clinical picture suggests neurodegeneration but the MRI is equivocal. A 2018 Cochrane review of 14 studies (N = 1,540) found that FDG-PET had 90% sensitivity and 80% specificity for differentiating Alzheimer disease from other dementias [14]. Left temporoparietal hypometabolism on FDG-PET is the characteristic pattern in logopenic variant PPA.

Amyloid PET (florbetapir, florbetaben, or flutemetamol) is now covered by Medicare under the Imaging Dementia Evidence for Amyloid Scanning (IDEAS) study criteria when the result would change clinical management [15]. A positive amyloid PET in a patient with progressive anomia shifts the diagnosis toward Alzheimer pathology and may affect eligibility for anti-amyloid therapies such as lecanemab.

Neuropsychological testing remains the gold standard for characterizing the pattern and severity of cognitive impairment. A full battery takes 3 to 6 hours and tests naming (Boston Naming Test), verbal fluency (FAS and animal naming), memory, attention, visuospatial function, and executive function. The Boston Naming Test alone takes about 15 minutes and consists of 60 line drawings of objects ranging from common (bed, tree) to rare (abacus, protractor). Scores below 48 out of 60 in adults aged 55 to 65 fall below the 10th percentile and warrant clinical attention [16].

Brief screening tools like the Montreal Cognitive Assessment (MoCA) can detect word finding difficulty through its naming (3 points), verbal fluency (1 point), and delayed recall (5 points) subtests. The MoCA has 90% sensitivity for mild cognitive impairment at a cutoff of 26 out of 30, compared to 18% sensitivity for the older Mini-Mental State Examination [17].

When Word Finding Difficulty Signals Something Serious

Three patterns should prompt urgent evaluation. Acute onset (hours to days) of word finding difficulty suggests stroke until proven otherwise, particularly if accompanied by right-sided weakness or right visual field loss. Left middle cerebral artery strokes affecting Wernicke's or Broca's area produce acute anomia, and time-to-treatment determines outcomes. The AHA/ASA guideline target for IV alteplase is within 4.5 hours of symptom onset [18].

Subacute onset (weeks) with headache, fever, or personality change raises concern for encephalitis, particularly herpes simplex encephalitis (HSE), which has a predilection for the temporal lobes. HSE is fatal in 70% of untreated cases; IV acyclovir must start empirically before confirmatory testing returns [19].

Progressive worsening over months with preserved memory and behavior suggests primary progressive aphasia. Referral to a behavioral neurologist or academic memory center is appropriate.

The reassuring pattern: stable, infrequent TOT episodes without decline in other cognitive domains, no functional impairment, normal neurological exam, and normal lab panel. This pattern in adults under 65 almost always reflects normal aging, stress, or sleep deprivation.

"The distinction between benign age-related word finding difficulty and early neurodegeneration requires longitudinal observation. A single snapshot is rarely diagnostic." This position is reflected in the 2023 NIA-AA revised diagnostic criteria for Alzheimer disease, which require evidence of cognitive decline over time rather than a single abnormal test result [20].

Medications That Can Impair Word Retrieval

Drug-induced anomia is common and reversible. The Beers Criteria, updated in 2023 by the American Geriatrics Society, flag several medication classes for cognitive adverse effects in older adults [21].

Topiramate is the most notorious offender. A randomized trial of topiramate for migraine prophylaxis found that 11% of patients on 200 mg daily reported word finding difficulty severe enough to prompt discontinuation, compared to 2% on placebo [22]. The mechanism involves carbonic anhydrase inhibition in the cerebral cortex.

Anticholinergics (diphenhydramine, oxybutynin, tricyclic antidepressants, first-generation antihistamines) block muscarinic receptors in the hippocampus and cortex. A 2015 JAMA Internal Medicine study of 3,434 adults over 65 found that cumulative anticholinergic use over 10 years was associated with a 54% increased risk of dementia (adjusted hazard ratio 1.54, 95% CI 1.21 to 1.96) [23].

Benzodiazepines impair encoding and retrieval. The effect is dose-dependent and partially reversible with discontinuation, though a 2014 BMJ study found that past benzodiazepine use (more than 3 months' cumulative exposure) was associated with a 51% increased risk of Alzheimer disease (adjusted OR 1.51, 95% CI 1.36 to 1.69) [24].

Statins have generated debate. A 2019 systematic review of 25 studies in the Journal of General Internal Medicine found no consistent association between statin use and cognitive impairment, though the FDA label includes a precaution for "ill-defined memory loss" based on post-marketing reports [25]. If a temporal relationship is clear (symptoms starting within weeks of initiation), a statin holiday with re-challenge can clarify causation.

Other common culprits include gabapentin, pregabalin, zonisamide, levetiracetam, and high-dose opioids. A thorough medication reconciliation should precede any advanced testing.

Treatment Based on Root Cause

Treatment follows diagnosis. There is no universal "fix" for word finding difficulty because anomia is a symptom, not a disease.

For hypothyroidism, levothyroxine replacement with a target TSH of 0.5 to 2.5 mIU/L typically improves verbal fluency within 3 to 6 months. A prospective Dutch study of 141 women with subclinical hypothyroidism showed statistically significant improvement in word retrieval speed after 12 weeks of levothyroxine versus placebo [26].

For B12 deficiency, intramuscular cyanocobalamin 1,000 mcg daily for 7 days, then weekly for 4 weeks, then monthly, is the standard repletion protocol per the AAN guideline. Oral high-dose B12 (1,000 to 2,000 mcg daily) is an acceptable alternative when absorption is intact [5]. Cognitive improvement depends on the duration of deficiency; deficits present for longer than 12 months may be only partially reversible.

For medication-induced anomia, the approach is straightforward: taper or discontinue the offending agent when clinically safe, then reassess cognition at 4 to 12 weeks.

For Alzheimer disease with prominent anomia, cholinesterase inhibitors (donepezil 10 mg daily, rivastigmine patch 13.3 mg/24 hr) remain first-line pharmacotherapy. The 2021 AAN practice guideline recommends offering cholinesterase inhibitors to patients with mild-to-moderate Alzheimer disease based on modest but consistent benefits in language and global cognition [27]. Lecanemab (Leqembi), an anti-amyloid monoclonal antibody, received traditional FDA approval in July 2023 based on the Clarity AD trial (N = 1,795), which showed a 27% slowing of cognitive decline at 18 months versus placebo [28].

For primary progressive aphasia, speech-language therapy focused on naming and word retrieval exercises has the strongest evidence. A 2020 systematic review of 18 studies in Aphasiology found that lexical retrieval therapy improved naming accuracy in PPA, with gains maintained at 6-month follow-up when home practice was maintained [29].

Lifestyle Factors That Affect Word Retrieval

Sleep is the single most modifiable factor. Seven to nine hours per night is the American Academy of Sleep Medicine recommendation for adults. The Wisconsin Sleep Cohort Study found that participants with untreated obstructive sleep apnea (AHI >15 events/hour) had 2.3 times the rate of verbal fluency decline over 10 years compared to controls [30]. Treating OSA with CPAP partially reversed these deficits.

Aerobic exercise at 150 minutes per week (moderate intensity) improved verbal fluency scores by 0.4 standard deviations in a 12-month randomized trial of 120 older adults published in the Proceedings of the National Academy of Sciences [31]. The effect was mediated by increased hippocampal volume on MRI.

Chronic stress and elevated cortisol impair hippocampal function. A Framingham Heart Study analysis found that participants with the highest tertile of morning cortisol had significantly worse performance on verbal memory and fluency tests, independent of age, sex, and education [13].

Alcohol use above 14 drinks per week was associated with accelerated hippocampal atrophy and verbal fluency decline in a 30-year longitudinal study of 550 adults published in the BMJ [32].

The practical prescription: sleep 7 to 9 hours, exercise at moderate intensity for 30 minutes five days per week, limit alcohol to 7 or fewer drinks per week, and address chronic stress through evidence-based approaches (CBT, mindfulness-based stress reduction). If word finding difficulty persists despite optimizing these factors and normalizing labs, proceed to neuropsychological testing and specialist referral.